Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer  

作　　者：Peter Schmid 

机构地区：[1]不详

出　　处：《四川生理科学杂志》2023年第10期1917-1917,共1页Sichuan Journal of Physiological Sciences

摘　　要：Background:Unresectable locally advanced or metastatic triple-negative(hormone-receptor-negative and human epidermal growth factor receptor 2[HER2]-negative)breast cancer is an aggressive disease with poor outcomes.Nanoparticle albumin-bound(nab)-paclitaxel may enhance the anticancer activity of atezolizumab.

关 键 词：BREAST CANCER PACLITAXEL 

分 类 号：R737.9[医药卫生—肿瘤]